Charles Carter
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles Carter
Charles Carter is recorded as CFO at Ovid Therapeutics Inc. (OVID). Ovid Therapeutics Inc. reported in an 8-K filed July 8, 2026 that Charles Carter was appointed Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective July 6, 2026.
“the Company's Board of Directors (the "Board") appointed Charles Carter, the Company's Senior Vice President of Finance and Financial Planning, as the Company's Chief Financial Officer, principal financial officer, principal accounting officer and secretary, effective as of the Separation Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ovid Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Margaret "Meg" Alexander CEO, COO, Board Member
- Margaret Alexander CEO, COO, Board Member
- Jeremy M. Levin Chairman
- Jeffrey Rona CFO, Chief Accounting Officer
- Anna Greka, M.D., Ph.D. Board Member
- Dr. Kevin Fitzgerald, Ph.D. Board Member
- Dr. Robert Michael Poole Board Member
- Stelios Papadopoulos, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.